PDS Biotechnology Corporation
NASDAQ:PDSB
1.39 (USD) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | ||||||||||||
Net Income
| -42.942 | -40.855 | -16.918 | -14.847 | -6.999 | -40.868 | -50.86 | -38.821 | -28.079 | -12.201 | -6.883 | -4.698 |
Depreciation & Amortization
| 0.017 | 0 | 0.005 | 0.016 | 0.098 | 0.174 | 0.183 | 0.1 | 0.053 | 0.031 | 0.004 | 0.002 |
Deferred Income Tax
| -1.965 | 0 | 0 | 0 | -0.382 | 2.823 | 0.141 | 0.269 | 0.199 | 0.035 | 0 | 0 |
Stock Based Compensation
| 7.614 | 5.196 | 4.11 | 0.452 | 3.176 | 7.615 | 6.4 | 5.305 | 2.899 | 1.298 | 0.26 | 0 |
Change In Working Capital
| -0.199 | 4.475 | 0.076 | 1.07 | -4.605 | -3.428 | 3.074 | 0.782 | 1.256 | 1.698 | -2.281 | 2.101 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 5.764 | -0.09 | -0.106 | 0.218 | -1.978 | -3.97 | 0.898 | 1.421 | -0.072 | 0.527 | -1.661 | 0 |
Other Working Capital
| -5.963 | 4.565 | 0.182 | 0.852 | -2.627 | 0.541 | 2.176 | -0.638 | 1.328 | 1.171 | -0.62 | 2.101 |
Other Non Cash Items
| 3.839 | 5.474 | 0.241 | 0.161 | -9.363 | 0.532 | 0.364 | 0.176 | 1.918 | -0.576 | 0.854 | 0.348 |
Operating Cash Flow
| -33.636 | -25.71 | -12.486 | -13.149 | -18.073 | -33.153 | -40.697 | -32.189 | -21.753 | -9.715 | -8.045 | -2.246 |
Investing Activities: | ||||||||||||
Investments In Property Plant And Equipment
| -0 | 0 | 0 | 0 | 0 | 0 | -0.189 | -0.687 | -1.305 | -0.885 | -0.137 | -0.001 |
Acquisitions Net
| 0 | 0 | 0 | 0 | 29.107 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| 0 | 0 | 0 | 0 | 0.275 | 0 | 0 | -0.687 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| 0 | 0 | 0 | 0 | 29.382 | 0 | -0.189 | -0.687 | -1.305 | -0.885 | -0.137 | -0.001 |
Financing Activities: | ||||||||||||
Debt Repayment
| -0.059 | 25 | 0 | 0 | 0 | -0.016 | 5 | 9.534 | 2.466 | 1.554 | 0.1 | 0.15 |
Common Stock Issued
| 16.127 | 9.856 | 48.545 | 29.757 | 0.75 | 1.513 | 17.383 | -0.23 | 86.059 | 0 | 0 | 2.223 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.022 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| 0.309 | -0.569 | 0.344 | 0.07 | 0 | 1.513 | 0.171 | -0.219 | 50.993 | 14.917 | 15.821 | 0 |
Financing Cash Flow
| 16.376 | 34.287 | 48.889 | 29.827 | 0.75 | -20.269 | 22.554 | 9.085 | 139.518 | 16.471 | 15.899 | 2.373 |
Other Information: | ||||||||||||
Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net Change In Cash
| -17.26 | 8.578 | 36.403 | 16.678 | 12.058 | -53.422 | -18.331 | -23.791 | 116.46 | 5.871 | 7.717 | 0 |
Cash At End Of Period
| 56.561 | 73.82 | 65.243 | 28.84 | 12.162 | 34.646 | 88.068 | 106.399 | 130.189 | 13.729 | 7.858 | 0.141 |